Novel Agent May Be Game-Changer in Rare Genetic Disease Novel Agent May Be Game-Changer in Rare Genetic Disease
Patients with von Hippel-Lindau face a high risk of renal cell carcinoma and other cancers, which often require multiple surgeries. A new drug may change the course of the disease.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hematology | Intensive Care | Kidney Cancer | Renal Cell Carcinoma